Treating residual cardiovascular risk - Will lipoprotein-associated phospholipase A(2) inhibition live up to its promise?
Erstveröffentlichung
2008
Wissenschaftlicher Artikel
Published in
Journal of the American College of Cardiology ; 51 (2008), 17. - S. 1642-1644. - ISSN 0735-1097. - eISSN 1558-3597
Link to publication
https://dx.doi.org/10.1016/j.jacc.2008.02.025Institutions
UKU. Klinik für Innere Medizin IISubject headings
[Free subject headings]: ENDOTHELIAL DYSFUNCTION | DISEASE | ATHEROSCLEROSIS[DDC subject group]: DDC 610 / Medicine & health